Q1 2024 361% growth in assets to $181.0 million following Solar Flow-Through Funds Ltd. Acquisition This news release constitutes a "designated news release" for the purposes of the Company's ...

Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% Y/Y Reiterates guidance to ...

The Company is required to file its Annual Filings all in accordance with IFRS within 120 days after the end of its completed financial year, such date being November 29, 2024 (the " Annual Filing ...

DUBLIN, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Learn about the best of the safest investments. Find out which investment categories offer the best protection for your principal and compare their advantages.